Cleviprex - Blood Pressure Control with a Focus on Stroke Patients

Dawn Meyer PhD,FNP-C,FAHA Professor UC San Diego School of Medicine, Department of Neurosciences UC San Diego Stroke Center Dawn Meyer is a Professor in the UC San Diego School of Medicine, Neurosciences Department and a member if the UC San Diego Stroke Center. She is a trained Vascular Neurology Nurse Practitioner and has been in practice for 21 years as a Stroke Hospitalist. She trained in Vascular Neurology at the University of Texas Health Science Center at Houston, completed her PhD at UCLA focusing on antiplatelets and sex differences in a preclinical model of stroke, and has been a faculty member of UCSD School of Medicine for 13 years. The overarching focus of her research is the interaction of platelet aggregation, sex differences, and depression in acute stroke. Her daily clinical practice focuses on the acute diagnosis, treatment, and risk factor modification in ischemic stroke, transient ischemic attack, and intracerebral hemorrhage patients. She was the first to show that antiplatelet loading improved stroke behavioral outcome in a preclinical model of ischemic stroke. In 2013, she was elected as a Fellow to the American Heart Association. She has published in top-tier stroke journals and has been a co-investigator in over 50 clinical stroke studies, site PI in 4 NIH studies, and PI of two NIH grants. Her current work focuses on the entire spectrum of stroke from translational to outcome studies with emphasis on antiplatelets. 4/16/2024 Dawn Meyer is a Professor in the UC San Diego School of Medicine, Neurosciences Department and a member if the UC San Diego Stroke Center. She is a trained Vascular Neurology Nurse Practitioner and has been in practice for 22 years as a Stroke Hospitalist. She trained in Vascular Neurology at the University of Texas Health Science Center at Houston, completed her PhD at UCLA focusing on antiplatelets and sex differences in a preclinical model of stroke, and has been a faculty member in the UCSD School of Medicine for 15 years. She was the first to show that antiplatelet loading improved stroke behavioral outcome in a preclinical model of ischemic stroke. In 2013, she was elected as a Fellow to the American Heart Association. She has published in top-tier stroke journals and has been a co-investigator in over 50 clinical stroke studies, site PI in 6 NIH studies, and PI of two NIH grants. The overarching focus of her research is the interaction of platelet aggregation, sex differences, and acute stroke. Her daily clinical practice focuses on the acute diagnosis, treatment, and risk factor modification in ischemic stroke, transient ischemic attack, and intracerebral hemorrhage patients at UCSDs 2 Comprehensive Stroke Centers.